Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Leukemia
 More »

  • Hematologic Diagnostics Go with the Flow
    ... in acute myeloid leukemia and myelodysplastic syndrome using flow cytometry methodologies. ... disease in pediatric patients with acute lymphoblastic leukemia after induction therapy. ...
    8-1-2013
  • Life Tech Licenses Dynabeads to Novartis, with Cancer Therapy...
    Earlier this year, a study in the New England Journal of Medicine described complete responses, one of them ongoing, in two children with leukemia. "Dynabeads ® CD3/CD28 CTS(tm) ...
    8-1-2013
  • High School Whiz Kids Win Scientific Prestige . . . and Big Bucks
    ... As a senior high school student in 2013, Brittany, who enjoys playing soccer, developed a computer algorithm to diagnose leukemia. She has set her sights on becoming a pediatric ...
    8-1-2013
  • Do VSELs Hold Water?
    Dr. Ratajczak and his colleagues reported in the May 20, 2006, issue of the journal Leukemia that he and his colleagues had found these cells with some of the properties of adult ...
    7-31-2013
  • Servier to Develop Nerviano Anticancer Compounds in Up to $143...
    hepatocellular carcinoma (HCC), danusertib for solid tumors and chronic myeloid leukemia (CML), and milciclib for thymic carcinoma in patients previously treated with chemotherapy. ...
    7-30-2013
  • Celgene Raises Acetylon Stake with Option to Buy for Potentially...
    or relapsed/refractory multiple myeloma. Last year, Acetylon teamed up with the Leukemia and Lymphoma Society to begin recruiting patients for ongoing studies-a Phase I a&b ...
    7-29-2013
  • Genentech Trumpets Phase III Results for CLL Candidate
    Roche's Genentech subsidiary today trumpeted successful second-stage Phase III results for its GA101 or obinutuzumab for the blood cancer chronic lymphocytic leukemia (CLL), saying ...
    7-24-2013
  • Celgene Halts a Phase III B-Cell CLL Trial Because of Deaths
    older with B-cell chronic lymphocytic leukemia (CLL), plus comorbidities that precluded ... It added that "all other Celgene-sponsored chronic lymphocytic leukemia clinical trials ...
    7-18-2013
  • Royalty Pharma Buys Quest Cancer Candidate Royalty Rights for...
    an interest in ibrutinib, an exciting potential therapy addressing the needs of patients with chronic lymphocytic leukemia, small lymphocytic lymphoma and mantle cell lymphoma." ...
    7-18-2013
  • M&A Doubleheader: Two Ailing Companies Bought Out
    milestones for Marqibo® (an FDA-approved hematology product for the treatment of leukemia), and an approval-based milestone for Menadione Topical Lotion (a Phase II product ...
    7-17-2013
  • Roche Buys CMI, Creates Hematology Dx Hub In $220M+ Deal
    products, which now include a testing system in development that is designed to provide faster and more accurate diagnosis of blood-related diseases, such as anemia and leukemia. ...
    7-3-2013
  • Targeting Deranged Metabolism to Treat Cancer
    (IDH) mutations (IDH1 and IDH2) in leukemia and glioblastoma have introduced a ... identified in gliomas, acute myeloid leukemia (AML), and chondrosarcomas, and all ...
    7-1-2013
  • Cancer's Bitter Medicine
    [Sergey Baybara/Fotolia] Some 120 investigators and other experts in chronic myeloid leukemia (CML) from 15 countries revisited a sore topic within the biopharma industry recently ...
    6-15-2013
  • Macrocycles Shake Up Small Molecules
    ... However, no inhibitors had been reported for this kinase despite its association with acute myeloid leukemia, multiple myeloma, and other forms of cancer," Dr. Smithgall explained. ...
    6-15-2013
  • Cancer: Why Some Stem Cells Cause Tumors
    Researchers at the University of Cambridge today show that a single mutation in a leukemia... by the overproduction of mature blood cells as well as an increased risk of leukemia. ...
    6-4-2013
  • More »

    Journal Articles

  • Regimen specific effects of RNA-modified chimeric antigen receptor...
    David Maxwell Barrett, Xiaojun Liu, Shuguang Jiang, Carl H June, Stephan A Grupp, Yangbing Zhao
    Human Gene Therapy and Part B: Methods
    receptor T cells in mice with advanced leukemia Human Gene Therapy and Part B: Methods ... improved survival and sustained anti-tumor responses in a robust leukemia xenograft model. ...
  • Endogenous Erythroid Colony Formation in Chronic Myeloid Leukemia...
    Elisa Einwallner, Eva Jaeger, Gerlinde Mitterbauer-Hohendanner, Martin Bilban, Ingrid Simonitsch-Klupp, Irene Steiner, Elisabeth Pernicka, Gregor Hoermann, Susanne Herndlhofer, Christian Sillaber, Peter Valent, Ilse Schwarzinger
    Stem Cells and Development
    Endogenous Erythroid Colony Formation in Chronic Myeloid Leukemia: A Recurrent Finding Associated with Persistent Minimal Residual Disease under Imatinib Stem Cells and Development
  • Antiproliferative Activities of Lesser Galangal ( Alpinia officinarum...
    Samson N. Omoregie, Felix O. Omoruyi, Vincent F. Wright, Lemore Jones, Paul V. Zimba
    Journal of Medicinal Food
    Rosc.) Against Acute Monocytic Leukemia Journal of Medicinal Food Acute monocytic leukemia (AML M5 or AMoL) is one of several types of leukemia that are still awaiting cures. ...
  • Regulation of Human RNase-L by the miR-29 Family Reveals a Novel...
    Teresa Y. Lee, Heather J. Ezelle, Thiagarajan Venkataraman, Rena G. Lapidus, Kara A. Scheibner, Bret A. Hassel
    Journal of Interferon & Cytokine Research
    Regulation of Human RNase-L by the miR-29 Family Reveals a Novel Oncogenic Role in Chronic Myelogenous Leukemia Journal of Interferon & Cytokine Research

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll